Desai Kashappa Goud
Biopharmaceutical Product Sciences, GlaxoSmithKline, 709 Swedeland Road, King of Prussia, PA 19406.
Crit Rev Ther Drug Carrier Syst. 2016;33(2):107-58. doi: 10.1615/CritRevTherDrugCarrierSyst.2016014850.
The objective of this review is to summarize recent advances in chitosan nanoparticles prepared by ionotropic gelation. Significant progress has occurred in this area since the method was first reported. The gelation technique has been improved through a number of creative methodological modifications. Ionotropic gelation via electrospraying and spinning disc processing produces nanoparticles with a more uniform size distribution. Large-scale manufacturing of the nanoparticles can be achieved with the latter approach. Hydrophobic and hydrophilic drugs can be simultaneously encapsulated with high efficiency by emulsification followed by ionic gelation. The turbulent mixing approach facilitates nanoparticle formation at a relatively high polymer concentration (5 mg/mL). The technique can be easily tuned to achieve the desired polymer/surface modifications (e.g., blending, coating, and surface conjugation). Using factorial-design-based approaches, optimal conditions for nanoparticle formation can be determined with a minimum number of experiments. New insights have been gained into the mechanism of chitosan-tripolyphosphate nanoparticle formation. Chitosan nanoparticles prepared by ionotropic gelation tend to aggregate/agglomerate in unfavorable environments. Factors influencing this phenomenon and strategies that can be adopted to minimize the instability are discussed. Ionically cross-linked nanoparticles based on native chitosan and modified chitosan have shown excellent efficacy for controlled and targeted drug-delivery applications.
本综述的目的是总结离子凝胶法制备壳聚糖纳米粒的最新进展。自该方法首次报道以来,这一领域已取得显著进展。通过一些创新性的方法改进,凝胶技术得到了改善。通过电喷雾和旋转盘处理进行的离子凝胶化可产生尺寸分布更均匀的纳米粒。后一种方法可实现纳米粒的大规模生产。通过乳化后进行离子凝胶化,疏水性和亲水性药物可同时高效包封。湍流混合方法有助于在相对较高的聚合物浓度(5mg/mL)下形成纳米粒。该技术可轻松调整以实现所需的聚合物/表面修饰(例如共混、涂层和表面共轭)。使用基于析因设计的方法,只需最少的实验次数就能确定纳米粒形成的最佳条件。对壳聚糖-三聚磷酸纳米粒的形成机制有了新的认识。离子凝胶法制备的壳聚糖纳米粒在不利环境中容易聚集/团聚。讨论了影响这一现象的因素以及可采取的使不稳定性最小化的策略。基于天然壳聚糖和改性壳聚糖的离子交联纳米粒在控释和靶向给药应用中已显示出优异的效果。